MARKET

DMAAR

DMAAR

Drugs Made In Amer Acqutn Corp
NASDAQ
0.1250
-0.0013
-1.03%
Closed 15:28 09/25 EDT
OPEN
0.1051
PREV CLOSE
0.1263
HIGH
0.1264
LOW
0.1000
VOLUME
30.67K
TURNOVER
--
52 WEEK HIGH
0.2395
52 WEEK LOW
0.0400
MARKET CAP
--
P/E (TTM)
0.5961
1D
5D
1M
3M
1Y
5Y
1D
DRUGS MADE IN AMERICA ACQUISITION CORP. FORM 10-Q
Press release · 08/15 01:41
About DMAAR
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.

Webull offers Drugs Made In America Acquisition Corp stock information, including NASDAQ: DMAAR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DMAAR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DMAAR stock methods without spending real money on the virtual paper trading platform.